ISAR Webinar Series
ISAR hosted Webinar on SARS CoV-2/COVID-19 biology and antivirals, presented by a Key Opinion Leader, Dr Mark Denison (Vanderbilt University) Considering the global significance and urgency, ISAR organized an online webinar by a key opinion leader and a subject matter expert, Mark Denison, MD, Director, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN on February 27, 2020. The Society’s Webinar Series coordinator, Raj Kalkeri, hosted the webinar and Rob Jordan moderated the session. Dr Mark Denison’s lab is engaged in preclinical development of remedisivir and other nucleoside analogs for use against SARS-CoV, MERS-CoV and other potentially zoonotic CoVs. The GoToWebinar platform was used for the webinar. The webinar discussed the biology of coronaviruses, current antivirals in development, and targets for broad-based antivirals. The webinar was followed by an interactive question & answer session. 277 people registered for the webinar, of whom 101 people attended the online event live. The webinar was recorded and, as an exception, is offered to both ISAR members and non-members in our quest to help the antiviral community’s efforts against SARS CoV-2. Webinar recording can be accessed on the GoToWebinar platform after registration (name and email address). |
